Tea and lycopene protect against prostate cancer by Jian, Le et al.




Tea and lycopene protect against prostate cancer 
 
Le Jian MD PhD1, 2, Andy H Lee PhD 2 and Colin W Binns MBBS PhD 2 
 
1Medical College of Zhejiang University, Hangzhou, PR China 
2School of Public Health, Curtin University of Technology, Western Australia 
 
 
Prostate cancer is the most common male cancer in developed countries and is increasing in the developing 
world. Its long latency and geographical variation suggest the possibility of prevention or postponement of onset 
by dietary modification.  To investigate the possible joint effect of lycopene and green tea on prostate cancer risk, 
a case-control study was conducted in Hangzhou, China, with 130 prostate cancer patients and 274 hospital con-
trols.  Information on tea and dietary intakes, and possible confounders was collected using a structured ques-
tionnaire.  The risk of prostate cancer for the intake of tea and lycopene and their joint effect were assessed using 
multivariate logistic regression models.  Prostate cancer risk was reduced with increased consumption of green 
tea.  The protective effect of green tea was significant (odds ratio 0.14, 95% CI: 0.06-0.35) for the highest quar-
tile relative to the lowest after adjusting for total vegetables and fruits intakes and other potential confounding 
factors.  Intakes of vegetables and fruits rich in lycopene were also inversely associated with prostate cancer risk 
(odds ratio 0.18, 95% CI 0.08-0.39).  Interaction analysis showed that the protective effect from tea and lycopene 
consumption was synergistic (p<0.01).  This study suggests that habitual drinking tea and intakes of vegetables 
and fruits rich in lycopene could lead to a reduced risk of prostate cancer in Chinese men.  Together they have a 
stronger preventive effect than either component taken separately.  This is the first epidemiological study to in-
vestigate the joint effect between tea drinking and lycopene intake. 
 




Introduction   
Prostate cancer is the most commonly diagnosed non-skin 
cancer in men in western countries.  In contrast, the inci-
dence in developing countries such as China is considera-
bly lower (age standardized rate, ASR 1.7/100,000).  Large 
difference in incidence has been noted between different 
racial and ethnic groups with the highest in the USA (ASR 
104/100, 000).1, 2  Studies on immigrants from Asian coun-
tries to North America revealed that the incidence of pros-
tate cancer increased in immigrants compared with their 
native population.3, 4  The geographic variations in inci-
dence rate and the increased incidence in immigrants sug-
gest a significant role of environmental factors, including 
nutrition, for developing the disease.  The sharp increase 
incidence of prostate cancer worldwide in recent decade 
can be partly attributed to the increase in PSA screening. 
Whilst PSA testing is popular in China, PSA screening is 
not widespread and prostate cancer is typically diagnosed 
at an advanced stage. Thus, it is important to put forward 
strategies for primary prevention.   
Recent studies have shown that regular drinking tea and 
consumption of diet rich in vegetables and fruits are asso-
ciated with the reduced risk of cancers.5-8  Green tea may 
induce apoptosis and inhibit cancer cell growth through 
their antioxidant properties and by causing cell cycle ar-
rest.9, 10  Two recent case-control studies evaluated green 
tea and prostate cancer risk in Asian countries.6, 11  Both 
studies received high methodological quality ratings from 
the US FDA.12  The Chinese study showed drinking three 
cups of green tea per day was significantly associated with 
a reduced risk of prostate cancer (odds ratio 0.27, 95% CI 
0.15-0.48).6  However the Japanese study reported that 
drinking two to ten cups of green tea per day was not sig-
nificantly associated with prostate cancer risk (odds ratio 
0.67, 95% CI 0.27-1.64).11  A double-blind, placebo-
controlled clinical trial in Italy using 600 mg/d green tea 
catechins has shown encouraging results.7 
Red-orange, dark green vegetables and fruits are rich 
sources of carotenoids, including lycopene, carotene, lutin, 
zeaxanthin and cryptoxanthin.  Lycopene gives the red 
color to foods including tomatoes, tomato products, water-
melon, pink grapefruit, apricots, papaya and pink guavas.  
In Western countries, over 80% of dietary lycopene comes 
from the consumption of tomatoes and tomato-based prod-
ucts including tomato sauce/juice/soup, spaghetti sauce, 
salsa, chili, pasta and pizza sauce.14, 15  The ability of lyco-
pene to act as an antioxidant and scavenger of free radicals 
is considered as the most likely mechanism that could 
account for the hypothesized beneficial effects on human 
health.  Lycopene may quench singlet oxygen, interact with 
reactive oxygen species and prevent oxidative damage to 
lipoproteins and DNA.13  It may increase cell cycle arrest 
and induction of apoptosis in human prostate cancer cell 
lines.16, 17  A well-designed animal study compared the 
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Rats fed with tomato powder experienced a significant 
(26%) decrease in prostate cancer specific mortality.  The 
epidemiological study providing the strongest evidence 
thus far concerning tomatoes and prostate cancer preven-
tion was a cohort study in the USA.19  This study fol-
lowed 47,894 men.  Raw tomatoes and tomato sauce were 
the only fruits or vegetables from a 131-item FFQ found 
to be associated with a reduced risk of prostate cancer 
with RR=0.74 (95% CI: 0.58-0.93) and RR=0.66 (95% CI: 
0.49-0.90), respectively.  Our recent case-control study in 
Chinese men also showed a protective effect of red-
orange vegetables and fruits rich in carotenoids against 
prostate cancer.20 
The majority of studies so far have focused on individ-
ual foods or nutrients.  However free-living populations 
are simultaneously exposed to a variety of food items in 
one meal.  Phytochemicals in whole meals may behave 
differently to individual compounds given in experimen-
tal situations.  These complex exposure situations may 
result in different health outcomes.  Thus, investigating 
the health benefit of different diets and phytochemicals in 
terms of their joint effects is necessary in order to under-
stand their underlying protective mechanism against can-
cers.  This study aims to assess the possible joint effect of 




The subjects were men residing in Zhejiang Province for 
at least 10 years and over 45 years of age.  They were 
recruited during 2001 and 2002 at eight public hospitals 
in Hangzhou, capital of Zhejiang Province located in 
southeast China.  Potential participants with a history of 
stroke or Alzheimer’s disease were excluded to avoid 
memory error.  Cases were confirmed by histopathologi-
cal reports of prostate adenocarcinoma.  Controls were 
recruited in the same hospitals during the same period and 
had no previous diagnosis of malignancies confirmed by 
physical examination, x-ray, operation or biopsy. Among 
the 140 cases recruited, 130 (93%) were interviewed and 
10 (7%) declined to participate in the study, including one 
with Alzheimer’s disease.  Of the 284 eligible controls 
identified, 274 (96.5%) participated in the study.  Two 
men (3.5%) with Alzheimer’s disease and one with a his-
tory of stroke were excluded.   
 
Data collection  
The interviews were conducted using a structured ques-
tionnaire which included a quantitative FFQ component.  
The interviewer was blind to the final diagnosis when 
doing the interviews. The study protocol included instruc-
tions to follow the printed questionnaire exactly to avoid 
bias. The reproducibility and validity of the FFQ were 
assessed by several methods.21  Information on demo-
graphic characteristics, family history of prostate cancer, 
height, weight and physical activity, and medical history 
were also collected.  A reference recall period (5 years 
before diagnosis for cases and 5 years before interview 
for controls) was adopted.  Interviews were usually con-
ducted in the presence of next-of-kin to assist in recall.  
The study was approved by the Human Research Ethics 
Committee of Curtin University, the Zhejiang hospital 
administration and the doctors in charge of the relevant 
wards.  Informed consent was sought prior to interview.   
 
Dietary assessment 
The FFQ contained questions on 130 food items including 
all foods in the usual diet of Zhejiang residents.  The ha-
bitual frequencies and quantities of foods consumed per 
meal were recorded.   
 
Tea assessment  
Tea drinking questions included both qualitative and 
quantitative measurements.  Participants were first classi-
fied as “ever” or “never” (less than once per month) ha-
bitual tea drinkers.  Information on consumption pattern 
was then collected from those “ever” tea drinkers.  The 
details of measurement can be obtained from our previous 
paper.6  
 
Physical activity assessment 
Information on habitual physical activity was assessed in 
terms of type, intensity and duration.  Daily metabolic 
equivalent task (MET) scores were calculated by multi-
plying the reported duration of any activity by the respec-
tive intensity score and then summing over all activities.22 
 
Statistical analysis 
The data analysis was undertaken using the SPSS package 
(version 11; SPSS Inc., Chicago, IL, USA).  Independent-
samples t, Mann-Whitney and Chi-square tests were used 
to compare the demographic characteristics and potential 
risk factors between cases and controls.  Energy and nu-
trient intakes were calculated using the Chinese nutrient 
database established by the Institute of Nutrition and 
Food Health, Chinese Academy of Preventive Medicine.23  
Conversion of lycopene from food items was undertaken 
using the U.S.  Department of Agriculture Database 
(USDA) because of no available Chinese database.24  The 
level of supplementations among the participants were 
very low, therefore, they were not included in the analysis.  
Risk of prostate cancer for the intake of tea and lycopene 
and their joint effect were assessed by odds ratios (ORs) 
and their 95% confidence intervals (95% CI) using un-
conditional multivariate logistic regression models.  Each 
fitted regression equation adjusted for age, height, weight, 
body mass index (BMI), locality, education, income, 
marital status, family history of prostate cancer, physical 
activities (MET), intakes of fat and caloric.  The quanti-
ties of tea and lycopene intakes were classified into quar-
tiles.  Adjusted ORs were obtained with the lowest quar-
tile as the reference category.  In addition, when assessing 
green tea consumption, fresh vegetables and fruits were 
included for adjustment in the model.  Meanwhile, when 
assessing lycopene intakes, green tea intakes were 
weighted in the model.  When assessing their joint effect, 
a new variable (joint effect of tea and lycopene) was gen-
erated according to the match of each pair of established 
quartiles.  For example, if the case was both in the lowest 
quartile of green tea and lycopene consumptions, he was 
classified into the lowest quartile of the new variable, and 
vice versa.  If intakes of green tea and lycopene were not 
in the same category (level) e.g. green tea intake was in 
the lowest quartile but lycopene intake wasn’t, they were 
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categorized as “other combinations”.   
 
Results  
Table 1 shows the characteristics of the participants.   
Demographic characteristics such as age, education, in-
come and marital status were similar in both groups, as 
well as fat and caloric intakes.  Compared with the con-
trols, cases tended to have higher BMI, more prostate 
cancer patients in the family, drank less tea and ate less 
fresh vegetables and fruits.   
The relationships between green tea drinking, lycopene 
intakes and prostate cancer risk are presented in Table 2.
Table 1. Characteristics of participants   
 
 
Cases (N =130) Controls (N =274) 
 
Age at interview, mean years (SD) 
Height, mean cm (SD) 
Weight*, mean kg (SD) 
BMI*, mean kg m-2 (SD) 
Locality of residence, N (%)  
         Urban 
         Rural 
Education, N (%) 
         No formal education 
         Primary 
         Secondary  
         Tertiary  
Personal monthly income in 2000(RMB), N (%) 
         ≤ 500  
         501-1000 
        1001-2000 
         ≥ 2001 
Marital status, n (%) 
         Married,  
         Widowed, divorced, separated 
Prostate cancer in first-degree relatives*, N (%) 
         No 
         Yes 
         Unclear  
Weekly MET 
Fat, mean g day-1(SD)  
Calorie, mean kcal day-1(SD) 
Fresh vegetables and fruits*, mean g day-1(SD) 
Drink tea*, N (%) 
       No 
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Table 2. Quartiles of green tea, lycopene and their joint effect on prostate cancer risk 
 
 Cases Controls Crude OR (95.0 % C.I.) OR†  (95.0% C.I.) 
 Green tea leaves (g day-1)       
   (1) 0 58 53 1.00  1.00  
   (2) 0.3-2.9 50 110 0.42 (0.25-0.69) 0.45 (0.25-0.82) 
   (3) 3.0-4.9 13 48 0.25 (0.12-0.51) 0.24 (0.10-0.57) 
   (4) ≥5 9 63 0.13 (0.06-0.29)  0.13 (0.05-0.32) 
 Lycopene (μg day-1)       
   (1) <1609 55 68 1.00  1.00  
   (2) 1609-3081 32 69 0.57 (0.33-0.99) 0.47 (0.25-0.86) 
   (3) 3081-4917 30 69 0.54 (0.31-0.94) 0.40 (0.21-0.77) 
   (4) >4917 13 68 0.24 (0.12-0.47) 0.17 (0.08-0.39) 
 Joint effect of tea & lycopene       
    (1) Low 24 15 1.00  1.00  
    (2) Other combinations ‡ 92 192 0.30 (0.15-0.60) 0.28 (0.13-0.59) 
    (3) Middle 11 31 0.22 (0.09-0.57) 0.21 (0.08-0.57) 
    (4) High 3 36 0.05 (0.01-0.20) 0.03 (0.01-0.16) 
 
 
†Variables adjusted for: age at interview, locality (urban, rural), education (none, primary, secondary, tertiary), family income (RMB, 
≤500, 501-1000, 1001-2000, ≥2001), marital status (married, widowed/divorced/separated), family history of prostate cancer (yes, no, 
uncertain), MET, BMI, fat intakes and calories.  In addition, when analyzing green tea leaves intakes, total fresh vegetables and fruits were 
adjusted and when analyzing lycopene intakes, green tea consumption was adjusted.  ‡Intakes of green tea and lycopene were not in the 
same category (level) e.g.  green tea intakes in the lowest quartile bur lycopene intakes in the highest quartile 
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After adjusting for age, family history of prostate cancer 
and other demographic characteristics, BMI, MET, fat, 
caloric and fresh vegetables and fruits intakes, the OR 
was 0.13 (95% CI 0.05-0.32) for men who consumed at 
least 5 g green tea leaves daily compared with non-tea 
drinkers.  Similarly, men who consumed over 4917μg of 
lycopene daily had adjusted OR 0.17 (95% CI 0.08-0.39) 
compared with the lowest quartile (<1608.6μg day-1) of 
intake.   
The possible joint effects and interactions of tea and ly-
copene on prostate cancer risk are presented in Table 2 
and Table 3.  Compared with the independent effects of 
tea and lycopene on the cancer risk, the joint effect was 
0.03 (95% CI 0.007-0.164) in high dose combination 
group relative to low dose combination group.  The ad-
justed OR was 0.11 (95%CI 0.05-0.26) for high dose of 
both green tea and lycopene intakes relative to low dose 
of tea and lycopene intakes.   
 
Discussion  
Many risk factors such as age, race, and family history 
cannot be controlled.  However, research on risk of pros-
tate cancer suggests that some environmental and lifestyle 
factors might be modified to achieve better outcome in 
terms of decreasing the risk of the cancer.5, 6, 14, 25  In this 
study, we observed the synergistic protective effect of 
green tea and lycopene against prostate cancer.   
In recent years, there are increasing number of epide-
miological studies on “functional food” and their correla-
tions with cancers.  Phytochemicals in plants are often 
considered as the major bioactive compounds with human 
health benefits linked to their antioxidant activities.  Un-
fermented green tea leaves contain up to 30 percent dry 
weight of tea polyphenols.24  Lycopene is the most abun-
dant carotenoid in tomatoes, tomato products and water-
melon.  While both green tea and lycopene have been 
shown to prevent prostate cancer, we have found no pub-
lished studies examined their joint effects on prostate 
cancer.  As prostate cancer is a multifactor disease and 
food is consumed in meals, studies of the interactions of 
protective factors may provide useful information on pre-
vention.  The joint effects and the high consumption of 
tea and fresh vegetables and fruits in Asian countries may 
partially explain the different clinical incidence of pros-
tate cancer between countries.  To the best of our knowl-
edge, this is the first report that investigated the possible 
joint effect of green tea and lycopene consumption on 
prostate cancer risk in Chinese people, a population with 
low risk of the cancer.   
Nevertheless, attempt to investigate the joint effect of 
dietary factors on the risk of prostate cancer via a case-
control study is vulnerable to selection and information 
bias.  However, effort has been made to minimize the 
selection bias by recruiting participants from eight major 
public hospitals including four provincial hospitals and 
four city hospitals in Hangzhou.  The low refusal rate of 
participation in both case and control groups may also 
indirectly demonstrate our effort in minimizing selection 
bias.  Because of the latency of the cancer, the reference 
recall period was set at five years before diagnosis for 
cancer cases and five years before interview for controls.  
Therefore, the food and tea consumptions could represent 
habitual intakes before the onset of the disease.  More 
detailed information on tea and food consumption was 
collected in our study than other studies such as a recent 
cohort study from Japan, in which, only one question re-
lated to tea consumption and 36 on food items.26  In addi-
tion, the relationship of tea, lycopene, and prostate cancer 
risk was not established at the time of interview, so that 
information bias could be assumed to be minimum.  Fur-
thermore, people with Alzheimer’ disease or recent stroke 
were excluded to avoid memory error.  For participants 
who neither shopped for food nor cooked meals, 97% of 
interviews were conducted in the presence of participants’ 
next of kin to confirm the usual quantities and frequencies 
of habitual food and beverage consumption.  Standard 
containers were shown to the participants to help in recall.  
To avoid inter-interviewer bias, a single interviewer con-
ducted all interviews following the same protocol.  In 
addition, the risk of prostate cancer was assessed using 
adjusted OR and accounted for possible confounders.  In 
the logistic regression analysis, three sets of models were 
used separately to exam potential joint effects.   
In summary, diets rich in lycopene and green tea are 
inversely related to the prostate caner risk, together, they 
offer stronger preventive effect.  This preliminary study 
may provide an example for nutritional cancer epidemiol-
ogical studies for assessing the joint effect of foods and 
nutrients on cancer risks.  Further laboratory study is 
needed to understand the molecular mechanism and bio-
chemistry of the joint effect between phytochemicals. 
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